Jack R Wands Selected Research

Jack R Wands Research Topics

Disease

47	Neoplasms (Cancer) 04/2022 - 04/2002
33	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 03/2003
24	Insulin Resistance 01/2021 - 02/2005
12	Fatty Liver 02/2014 - 09/2006
11	Inflammation (Inflammations) 01/2021 - 08/2008
10	Alzheimer Disease (Alzheimer's Disease) 01/2009 - 01/2002
9	Cholangiocarcinoma 01/2021 - 05/2003
8	Infections 01/2016 - 02/2004
7	Neoplasm Metastasis (Metastasis) 04/2022 - 11/2004
7	Carcinogenesis 01/2021 - 01/2002
6	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2019 - 08/2007
6	Mitochondrial Diseases (Mitochondrial Disease) 06/2012 - 06/2004
5	Fibrosis (Cirrhosis) 01/2013 - 08/2004
5	Cognitive Dysfunction 01/2010 - 12/2005
5	Carcinoma (Carcinomatosis) 05/2009 - 07/2002
4	Adenocarcinoma 01/2019 - 07/2002
4	Colonic Neoplasms (Colon Cancer) 01/2016 - 09/2004
4	Type 2 Diabetes Mellitus (MODY) 04/2011 - 11/2008
4	Disease Progression 05/2009 - 03/2003
3	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2017
3	Non-alcoholic Fatty Liver Disease 01/2021 - 04/2012
3	Alcoholic Fatty Liver 08/2011 - 01/2009
3	Fetal Alcohol Spectrum Disorders 05/2009 - 09/2007
3	Alcoholism (Alcohol Abuse) 01/2009 - 09/2008
2	Triple Negative Breast Neoplasms 04/2022 - 01/2021
2	Hepatitis C 07/2014 - 02/2006
2	Liver Diseases (Liver Disease) 01/2012 - 08/2011
2	Hypoxia (Hypoxemia) 01/2012 - 09/2010
2	Weight Loss (Weight Reduction) 08/2011 - 01/2010
2	Alcoholic Hepatitis 04/2011 - 07/2009
2	Hepatitis 06/2009 - 11/2005
2	Virus Diseases (Viral Diseases) 06/2009 - 06/2007
2	Obesity 01/2009 - 11/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2007 - 07/2002
2	Neuroblastoma 12/2006 - 07/2002
2	Dementia (Dementias) 09/2006 - 01/2002

Drug/Important Bio-Agent (IBA)

25	Insulin (Novolin)FDA Link 01/2021 - 02/2005
24	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2002
20	Ethanol (Ethyl Alcohol)IBA 01/2019 - 08/2007
13	Mixed Function Oxygenases (Monooxygenases)IBA 04/2022 - 08/2006
13	CeramidesIBA 02/2014 - 01/2009
12	CytokinesIBA 01/2013 - 02/2006
11	Insulin-Like PeptidesIBA 04/2011 - 01/2002
11	aspartic acid 2-oxoglutarate-dependent dioxygenaseIBA 09/2010 - 07/2002
10	LipidsIBA 01/2021 - 04/2008
9	Aspartic Acid (Aspartate)FDA Link 04/2022 - 01/2012
8	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2010 - 12/2005
7	Biomarkers (Surrogate Marker)IBA 10/2014 - 01/2002
6	VaccinesIBA 04/2022 - 02/2006
6	Messenger RNA (mRNA)IBA 01/2021 - 09/2004
6	Protein Isoforms (Isoforms)IBA 10/2019 - 04/2011
6	CateninsIBA 07/2015 - 04/2011
5	AntigensIBA 04/2022 - 11/2004
5	Monoclonal AntibodiesIBA 01/2019 - 07/2002
5	beta CateninIBA 06/2009 - 10/2004
5	Insulin-Like Growth Factor I (IGF-1)IBA 09/2008 - 02/2005
4	EnzymesIBA 01/2021 - 02/2006
4	Pharmaceutical PreparationsIBA 10/2019 - 11/2004
4	Therapeutic UsesIBA 09/2017 - 09/2006
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 12/2006
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2013 - 01/2010
4	Insulin ReceptorIBA 01/2013 - 02/2005
4	DNA (Deoxyribonucleic Acid)IBA 03/2012 - 02/2005
4	Streptozocin (Streptozotocin)FDA Link 01/2009 - 02/2005
4	Amyloid beta-PeptidesIBA 01/2009 - 02/2005
3	Glycogen Synthase KinasesIBA 04/2016 - 03/2006
3	Contrast MediaIBA 03/2016 - 01/2015
3	Glucose (Dextrose)FDA LinkGeneric 04/2014 - 12/2005
3	Triglycerides (Triacylglycerol)IBA 05/2012 - 01/2009
3	Transcription Factors (Transcription Factor)IBA 05/2012 - 05/2006
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2009 - 05/2006
3	Uncoupling Protein 2IBA 04/2008 - 09/2004
2	LigandsIBA 04/2022 - 04/2002
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2021
2	DioxygenasesIBA 01/2021 - 10/2018
2	Ketoglutaric Acids (Ketoglutaric Acid)IBA 01/2021 - 10/2018
2	Phosphotransferases (Kinase)IBA 12/2017 - 08/2009
2	Hepatitis B e AntigensIBA 01/2016 - 03/2013
2	Small Interfering RNA (siRNA)IBA 01/2016 - 09/2010
2	AntibodiesIBA 10/2015 - 11/2004
2	Peptides (Polypeptides)IBA 03/2015 - 11/2004
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 04/2012 - 12/2011
2	Mitogen-Activated Protein KinasesIBA 03/2012 - 05/2003
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 12/2011 - 02/2005
2	AntioxidantsIBA 12/2011 - 05/2009
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 12/2011 - 09/2008
2	Phosphatidylethanolamine Binding ProteinIBA 01/2011 - 10/2006
2	Peptide Hydrolases (Proteases)FDA Link 11/2010 - 04/2002
2	Insulin Receptor Substrate ProteinsIBA 06/2009 - 11/2005
2	Glycogen Synthase Kinase 3 betaIBA 06/2009 - 09/2008
2	UbiquitinIBA 01/2009 - 03/2006
2	Amyloid (Amyloid Fibrils)IBA 11/2008 - 04/2007
2	Malondialdehyde (Propanedial)IBA 09/2006 - 09/2004
2	Oncogene Proteins (Oncogene Protein)IBA 08/2004 - 01/2002
2	AD7c-NTPIBA 06/2004 - 01/2002
2	SB 203580IBA 06/2003 - 05/2003
2	p38 Mitogen-Activated Protein KinasesIBA 06/2003 - 05/2003

Therapy/Procedure

10	Therapeutics 04/2022 - 11/2004
3	Immunotherapy 04/2022 - 01/2009
3	Drug Therapy (Chemotherapy) 01/2021 - 04/2008